Concurrent mutations in the coding and regulatory regions of HRAS in urinary bladder tumors are associated with increased Ras expression [29], and constitutively active HRAS triggers bladder carcinogenesis in mouse urothelium [10]. Here, HRAS is linked to urinary bladder neoplasm.